Fueling the fire in the gut

Area of Science:

• Immunology
• Microbiology
• Gastroenterology

Background:

• Gut dysbiosis is a known risk factor for inflammatory bowel diseases, including Crohn's disease.
• The specific mechanisms by which gut microbiota influence host immunity in disease remain under investigation.

Purpose of the Study:

• To investigate the role of microbiota-derived bioactive lipids in promoting pathological immune responses.
• To elucidate the mechanisms by which these lipids affect T helper 1 (Th1) cell responses.

Main Methods:

• Analysis of bioactive lipids produced by dysbiotic gut microbiota.
• In vitro studies on the effects of lysophosphatidylserines on Th1 cell metabolism and epigenetics.
• Assessment of Th1 cell differentiation and function.

Main Results:

• Lysophosphatidylserines (LPSers) derived from dysbiotic microbiota were identified as key mediators.
• LPSers induced metabolic reprogramming in Th1 cells, enhancing their pro-inflammatory functions.
• Epigenetic modifications were observed in Th1 cells upon exposure to LPSers, contributing to pathological responses.

Conclusions:

• Dysbiotic microbiota-derived lysophosphatidylserines are potent inducers of pathological Th1 cell responses.
• These lipids promote disease development by altering Th1 cell metabolism and epigenetics.
• Targeting these microbial metabolites may offer novel therapeutic strategies for Crohn's disease.